- Email: [email protected]
Lipoproteins and coronary heart disease
184 LIPOPROTEINS AND CORONARY HEART DISEASE
This international Symposium will b¢ held in Glasgow, Scotland on September 14th and 15th, 1984. The Scientific Programme is as follows: Session 1: Structure and Metabolism o f Lipoproteins - The structure of lipopro-
teins (Dr. H.B. Brewer Jr., Bcthesda, U.S.A.); Plasma lipoprotein metabolism (Dr. J. Shepherd, Glasgow); Cell.lipoprotein interactions (Dr. R.W. Mahley, San Francisco, U.S.A.); Enzymes involved in intravaseular lipoprotein metabolism (Dr. G.M. Kostner, Graz, Austria). Session 2: Mechanisms o f A therosclerosis - Cellular interactions in the development
of atherosclerosis (Dr. R. Ro~, Seattle, U.S.A.); Repair processes in arteries (Dr. S. Bjorkerud, Gotebord, Sweden); Cholesterol metabolism in macrophages and possible impact on atherosclerosis (Dr. G. Assman, Munster, F.R.G.), Growth factors in atherosclerosis (Dr. H. Antoniades, Boston, U.S.A.). Session 3: Risk Factors and Coronary Heart Disease - Identification of risk factors
for coronary heart di~as¢ (Dr. A.G. Shaper, London); The lipid research clinics coronary primary prevention trial (Dr. B.M. Rifkind, Bethe~la, U.S.A.); Studies of atherosclerosis regression in man (Dr. B. Lewis, London); A prospective study of coronary artery disease regression (Dr. E.A. Nikkila, Hel~inki, Finland); The high coronary risk individual: how to identify and treat (Dr. M,F. Oliver, Edinburgh, Scotland); Practical politics for prevention. The Glasgow plan (Dr. L. Davidson, Greater Glasgow Health Board). Further information may be obtained from: Miss Sheena M. Brownlie, Department of Biochemistry, Royal Infwmary, Glasgow G4 0SF, Scotland, U.K. (Tel.: (041) 552 3535, Ext. 5279, 24 hours).
This international Symposium will b¢ held in Glasgow, Scotland on September 14th and 15th, 1984. The Scientific Programme is as follows: Session 1: Structure and Metabolism o f Lipoproteins - The structure of lipopro-
teins (Dr. H.B. Brewer Jr., Bcthesda, U.S.A.); Plasma lipoprotein metabolism (Dr. J. Shepherd, Glasgow); Cell.lipoprotein interactions (Dr. R.W. Mahley, San Francisco, U.S.A.); Enzymes involved in intravaseular lipoprotein metabolism (Dr. G.M. Kostner, Graz, Austria). Session 2: Mechanisms o f A therosclerosis - Cellular interactions in the development
of atherosclerosis (Dr. R. Ro~, Seattle, U.S.A.); Repair processes in arteries (Dr. S. Bjorkerud, Gotebord, Sweden); Cholesterol metabolism in macrophages and possible impact on atherosclerosis (Dr. G. Assman, Munster, F.R.G.), Growth factors in atherosclerosis (Dr. H. Antoniades, Boston, U.S.A.). Session 3: Risk Factors and Coronary Heart Disease - Identification of risk factors
for coronary heart di~as¢ (Dr. A.G. Shaper, London); The lipid research clinics coronary primary prevention trial (Dr. B.M. Rifkind, Bethe~la, U.S.A.); Studies of atherosclerosis regression in man (Dr. B. Lewis, London); A prospective study of coronary artery disease regression (Dr. E.A. Nikkila, Hel~inki, Finland); The high coronary risk individual: how to identify and treat (Dr. M,F. Oliver, Edinburgh, Scotland); Practical politics for prevention. The Glasgow plan (Dr. L. Davidson, Greater Glasgow Health Board). Further information may be obtained from: Miss Sheena M. Brownlie, Department of Biochemistry, Royal Infwmary, Glasgow G4 0SF, Scotland, U.K. (Tel.: (041) 552 3535, Ext. 5279, 24 hours).